145 145 (Rivastigmine 1.5 mg)
Pill with imprint 145 145 is Yellow, Capsule-shape and has been identified as Rivastigmine tartrate 1.5 mg. It is supplied by Sun Pharmaceutical Industries Inc..
Rivastigmine is used in the treatment of parkinson's disease; alzheimer's disease; lewy body dementia and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 145 145
Rivastigmine tartrate
- Imprint:
- 145 145
- Strength:
- 1.5 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Cholinesterase inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Sun Pharmaceutical Industries Inc.
- Inactive Ingredients:
- magnesium stearate
microcrystalline cellulose
silicon dioxide
gelatin
titanium dioxide
D&C Red No. 28
D&C Yellow No. 10
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 68084-0550 | Amerisource Health Services |
More about rivastigmine
- Rivastigmine Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- 21 Reviews
- Drug class: cholinesterase inhibitors
Consumer resources
- Rivastigmine
- Rivastigmine transdermal
- Rivastigmine Capsules
- Rivastigmine Oral Solution
- Rivastigmine Patch
- ... +2 more
Other brands: Exelon
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
